GLP-1 and reduced cancer risk discovery earns UT Health San Antonio fellow prestigious Helio NextGen Disruptor Award
June 25, 2026
Colton Frisco Jones, MD, a 2nd-year fellow at the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio N …
UT San Antonio awarded $44 million NIH contract to advance landmark RURAL Cohort Study
April 30, 2026
The University of Texas at San Antonio has been awarded a five-year, $44 million contract from the National Heart, Lung, and Blood Institute of the National Institutes of Health for a landmark study focused on persistent health challenges in the rural South.
Widely used metabolic drugs may help curb rising colorectal cancer in younger adults
March 2, 2026
A large, retrospective study conducted by scientists at The University of Texas at San Antonio suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists — medications that are widely prescribed for metabolic disease — have a significantly lower risk of developing colorectal cancer compared with those taking aspirin.
UT Health San Antonio leads $4 million study on glucagon’s role in diabetes, obesity
November 11, 2025
The first-of-its-kind study will examine how glucagon contributes to insulin secretion, glucose regulation and energy balance in people with obesity who have or have not undergone bariatric surgery.
Pilot study: Branched-chain amino acids may help physical, mental fatigue in older adults
October 2, 2025
It is often said that exercise is the best medicine, but for many older adults, it can be a prescription that is increasingly difficult to take. Age-related physical and mental health challenges frequently make regular activity hard to sustain. …
Scientists pinpoint early warning stage before prediabetes
September 4, 2025
iStock photo A new study from The University of Texas at San Antonio Health Science Center indicates that changes in the body that lead to Type 2 diabetes occur long before current diagnostic thresholds for prediabetes are met. The first-of-its-kind st …
First national review of anti-aging compounds
July 28, 2025
The first comprehensive review of the NIH’s Interventions Testing Program was published in July 2025. Study finds rapamycin shows greatest longevity effect in 20-year NIH Interventions Testing Program The first comprehensive review of two decade …
Max and Minnie Tomerlin Voelcker Fund grants UT Health San Antonio $1.25 million to support research from early career investigators
July 2, 2025
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded $1.25 million by the Max and Minnie Tomerlin Voelcker Fund to support research projects being conducted by the institution’s early career inves …
UT Health San Antonio researchers discover new links between heart disease and dementia
May 30, 2025
People who are at higher risk for heart disease also seem more likely to develop dementia. And research led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered new associations between various l …
Metabolic treatment: A potential breakthrough in diabetic heart disease
May 1, 2025
SGLT2i-drug induced hyperketonemia improved cardiac function for Type 2 diabetic patients with heart failure Heart disease is the leading cause of death for people with Type 2 diabetes and people with diabetes are more than twice as likely to experienc …